Jan 01–04, 2027 | Location to be Determined
Scientific Organizers:
Ana Carrizosa Anderson

-
Scientific Organizers: Ana Carrizosa Anderson
Ana Carrizosa Anderson
***Meeting program subject to change.
Available Formats: = In Person = On DemandFriday, January 1, 2027
Merchandise Options
Registration Options
Saturday, January 2, 2027
How Tumors Enable Immunotherapy
Lessons from Checkpoint Blockade Trials
Neoadjuvant Checkpoint Blockade in MMRd Cancer
Understanding Resistance to Checkpoint Inhibition based on Neoadjuvant Clinical Trials
Rewiring T Cells in PD1 Resistant Tumors
Stromal and Immune Plasticity Shape the Metastatic Niche
Systems Cancer Pathology
Sunday, January 3, 2027
NK-CARS
Targeting Innate T Cells in Cancer (MAIT , gdT, and iNKT)
Macrophage Directed Immunotherapies
Trem2 based Therapies in Cancer
Early CD8+ T Cell Fate Commitment in Cancer
Talk Title to be Announced
Cytokine-Directed Gene Programs Shaping CD8+ T Cell Differentiation in Cancer
Monday, January 4, 2027
Engineering T Cell Cancer Therapies
Therapeutic Applications of CRISPR
Bi-Specific T Cell Engagers (BiTes)
Engineering Proteins for Immunotherapy
Novel Mechanisms Producing Targetable Tumor Antigens
Cancer Vaccines for Immunoprevention
Next Generation Cancer Vaccines
Tuesday, January 5, 2027
Subscribe for Updates